Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Mechanism EED inhibitors(Polycomb protein EED inhibitors), EZH2 inhibitors(Histone-lysine N-methyltransferase EZH2 inhibitors), SUZ12 inhibitors(SUZ12 polycomb repressive complex 2 subunit inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lymphoma | Preclinical | CN | 01 Nov 2023 | |
Lymphoma | Preclinical | CN | 01 Nov 2023 |